Top Analyst Ratings: February 13th, 2025

STA Research
February 13th, 2025
Top Analyst Ratings: June 9th, 2025
LinkedInBufferRedditTumblrWhatsApp

Top Analyst Ratings

  • Alibaba

    • Target Update by Jefferies & Company
    • Rating: Buy
    • Target Price: USD 150
    • Date: 02/13/2025
    • Details: Jefferies updated its target price for Alibaba, reflecting optimism about the company’s long-term growth potential, especially in areas like e-commerce, cloud services, and AI. The company’s market positioning in China and abroad provides a strong foundation for future performance.

  • Airbnb

    • Target Update by Bank of America Merrill Lynch
    • Rating: Hold
    • Target Price: USD 151
    • Date: 02/13/2025
    • Details: Bank of America Merrill Lynch maintained its “Hold” rating for Airbnb, suggesting that the stock is fairly valued. Despite solid revenue growth and positive outlooks, analysts see limited upside in the short term as the market adjusts to economic challenges.

  • Barrick Gold

    • Target Down by TD Securities
    • Rating: Buy
    • Target Price: CAD 33
    • Date: 02/13/2025
    • Details: TD Securities downgraded its target price for Barrick Gold, although it maintained a “Buy” rating. The lower target is attributed to weaker gold prices and increased operational costs. However, Barrick’s solid financial position and exploration potential are still seen as positive.

  • Brookfield Asset Management

    • Target Up by TD Securities
    • Rating: Buy
    • Target Price: CAD 40
    • Date: 02/13/2025
    • Details: TD Securities raised its target price for Brookfield Asset Management, citing positive performance from its global asset management and real estate operations. Analysts are bullish on the company’s diversified portfolio and strong growth prospects.

  • Canadian Tire

    • Maintains by CIBC World Markets
    • Rating: Neutral
    • Target Price: CAD 165
    • Date: 02/13/2025
    • Details: CIBC World Markets maintained a “Neutral” rating for Canadian Tire, indicating a balanced outlook. The company’s diversified business model, including retail and financial services, is seen as stable, but there are concerns about competition and economic conditions that may weigh on performance.

  • CVS Health

    • Target Raised by Truist Financial
    • Rating: Buy
    • Target Price: USD 76 (previously USD 60)
    • Date: 02/13/2025
    • Details: Truist Financial raised its target price for CVS Health due to the company’s improved revenue forecast, driven by strong performance in retail and healthcare services. CVS’s strategic shift towards healthcare solutions and its growth in pharmacy services are seen as catalysts for the price increase.

  • Dell Technologies

    • Target Lowered by Morgan Stanley & Co.
    • Rating: Overweight
    • Target Price: USD 128 (previously USD 154)
    • Date: 02/13/2025
    • Details: Morgan Stanley downgraded its target price for Dell Technologies, reflecting softer-than-expected demand for its enterprise and consumer products. The company’s hardware and software solutions face increasing competition, leading to lowered growth projections.

  • Emera Inc

    • Target Raised by Scotia Capital
    • Rating: Outperform
    • Target Price: CAD 62 (previously CAD 60)
    • Date: 02/13/2025
    • Details: Scotia Capital raised its target price for Emera, reflecting the company’s continued strong performance in its regulated utility operations. The company’s focus on clean energy and renewable projects is expected to drive future growth.

  • Fastly

    • Target Lowered by RBC
    • Rating: Sector Perform
    • Target Price: USD 8 (previously USD 10)
    • Date: 02/13/2025
    • Details: RBC lowered its target price for Fastly due to slower growth in demand for its content delivery network (CDN) services. Analysts cite increased competition in the cloud services sector and reduced market expectations for Fastly’s ability to meet aggressive targets.

  • Gilead Sciences

    • Upgraded by DZ Bank Group AG
    • Rating: Buy
    • Target Price: USD 108
    • Date: 02/13/2025
    • Details: DZ Bank Group upgraded Gilead Sciences, citing promising developments in its pipeline, particularly in oncology and HIV treatments. The company’s strategic partnerships and strong position in the pharmaceutical industry led to a positive outlook.

  • GlaxoSmithKline

    • Target Update by TD Cowen
    • Rating: Hold
    • Target Price: USD 45
    • Date: 02/13/2025
    • Details: TD Cowen maintained a “Hold” rating for GlaxoSmithKline, citing the company’s relatively stable performance. However, concerns about its ability to generate significant growth through its current product portfolio led to a cautious outlook.

  • HomeDepot

    • Target Raised by Wells Fargo & Company
    • Rating: Overweight
    • Target Price: USD 450 (previously USD 440)
    • Date: 02/13/2025
    • Details: Wells Fargo raised its target price for HomeDepot, reflecting strong growth in home improvement demand. Analysts believe the company will benefit from increased consumer spending on home renovation and repair projects in the coming quarters.

  • Kraft Heinz

    • Target Lowered by Stifel Nicolaus
    • Rating: Hold
    • Target Price: USD 31 (previously USD 32)
    • Date: 02/13/2025
    • Details: Stifel Nicolaus lowered its target price for Kraft Heinz, reflecting challenges in driving growth in its food business. Analysts believe competition and rising input costs could negatively impact the company’s profitability.

  • Robinhood

    • Target Raised by Needham & Company
    • Rating: Buy
    • Target Price: USD 70 (previously USD 52)
    • Date: 02/13/2025
    • Details: Needham & Company raised its target price for Robinhood, highlighting strong growth in the retail investment space. The company’s expanding customer base and continued momentum in options and crypto trading contributed to the positive outlook.

  • Sun Life Financial

    • Target Lowered by National Bank Financial
    • Rating: Outperform
    • Target Price: CAD 93 (previously CAD 95)
    • Date: 02/13/2025
    • Details: National Bank Financial lowered its target price for Sun Life Financial, reflecting some headwinds in its U.S. business. While growth in Asia remains strong, analysts note that the company’s earnings may be impacted by softness in its North American operations.

  • Walmart

    • Reiterates by Morgan Stanley & Co.
    • Rating: Overweight
    • Target Price: USD 115 (previously USD 106)
    • Date: 02/13/2025
    • Details: Morgan Stanley reiterated its “Overweight” rating for Walmart, raising its target price to reflect strong results from the retailer’s online and physical store operations. Analysts are bullish on Walmart’s strategy to maintain its market leadership in the retail sector, especially with its expanding grocery and e-commerce offerings.
Ad